Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials

被引：0
|
作者：
Liedtke, W [1 ]
Limmroth, V [1 ]
机构：
[1] NIH,OFF DIRECTOR,LAB DIAGNOST RADIOL RES,BETHESDA,MD 20892
来源：
ANNALS OF NEUROLOGY | 1996年 / 39卷 / 02期
关键词：
D O I：
10.1002/ana.410390221
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [21] Composite MRI score as a biomarker in clinical trials in multiple sclerosis
    Traboulsee, A
    Zhao, YS
    Li, D
    NEUROLOGY, 2006, 66 (05) : A73 - A74
  • [22] Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis
    Altmann, Dan
    Jasperse, B.
    Barkhof, Frederik
    Beckmann, Karola
    Filippi, Massimo
    Kappos, Ludwig
    Molyneux, P.
    Polman, Chris H.
    Pozzilli, Carlo
    Thompson, Alan J.
    Wagner, Klaus
    Yousry, Tarek
    Miller, David H.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S22 - S22
  • [23] MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis
    Koch, Marcus W.
    Mostert, Jop
    Repovic, Pavle
    Bowen, James D.
    Strijbis, Eva
    Uitdehaag, Bernard
    Cutter, Gary
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (04) : 561 - 572
  • [24] Daclizumab phase II trial in relapsing and remitting multiple sclerosis - MRI and clinical results
    Rose, J. W.
    Burns, J. B.
    Bjorklund, J.
    Klein, J.
    Watt, H. E.
    Carlson, G.
    NEUROLOGY, 2007, 69 (08) : 785 - 789
  • [25] Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
    Noble, J. Gareth
    Osborne, Lisa A.
    Jones, Kerina H.
    Middleton, Rod M.
    Ford, David V.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1718 - 1720
  • [26] Appropriate design and outcome measures in multiple sclerosis clinical trials
    Greenstein, JI
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (05) : 503 - 504
  • [27] Clinical outcome measures and rating scales in multiple sclerosis trials
    Wingerchuk, DM
    Noseworthy, JH
    Weinshenker, BG
    MAYO CLINIC PROCEEDINGS, 1997, 72 (11) : 1070 - 1079
  • [28] Diagnostic brain MRI findings in primary progressive multiple sclerosis
    Kremenchutzky, M
    Lee, D
    Rice, GPA
    Ebers, GC
    MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (02) : 81 - 85
  • [29] Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis (vol 23, pg 1, 2017)
    Cawley, N.
    Tur, C.
    Prados, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (13) : NP30 - NP30
  • [30] PROGRESSION PHASE OF MULTIPLE-SCLEROSIS NOT A USEFUL ENTRY CRITERION FOR THERAPEUTIC TRIALS
    MYERS, LW
    ELLISON, GW
    LEAKE, BD
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 312 - 312
12345